Personal information

Emails & domains

Verified email domains

Websites & social links

Utilities and tutorials for miRNA functional analysis
Linkedin profile
Researchgate profile
Twitter profile
Instagram Profile

Other IDs

Scopus Author ID: 6602119231
ResearcherID: A-2347-2009
Loop profile: 173306
Ciência ID: B215-8D49-3218
ResearcherID: A-2347-2009

Keywords

non-coding RNA, Next generation sequencing, miRNA, Structural Biology, lncRNA, Personalized medicine, Cardiovascular disease

Countries

Portugal

Activities

Collapse all

Employment (3)

Universidade de Lisboa: Lisbon, PT

2025-01-01 to present | Associate Professor (Faculdade de Medicina)
Employment
Source: Self-asserted source
Francisco J. Enguita

Universidade de Lisboa: Lisboa, Lisboa, PT

2008-05-01 to present | Assistant Professor (Faculade de Medicina)
Employment
Source: Self-asserted source
Francisco J. Enguita

Universidade Lusofona de Humanidades e Tecnologias: Lisbon, Lisbon, PT

2000-09-01 to 2007-10-01 | Professor (Health Sciences)
Employment
Source: Self-asserted source
Francisco J. Enguita

Education and qualifications (2)

Universidad de Salamanca: Salamanca, ES

1993-01-01 to 1998-10-01 | Ph.D. (Microbiology)
Education
Source: Self-asserted source
Francisco J. Enguita

Universidad de Granada: Granada, Granada, ES

1986-09-01 to 1991-07-13 | B.Pharm
Education
Source: Self-asserted source
Francisco J. Enguita

Peer review (26 reviews for 16 publications/grants)

Review activity for Biochemical genetics. (1)
Review activity for Biomedicines. (1)
Review activity for Biomolecules. (2)
Review activity for Cancer cell international. (5)
Review activity for Cell and tissue research. (1)
Review activity for Cells. (2)
Review activity for Cellular & Molecular Biology Letters. (1)
Review activity for Communications medicine. (1)
Review activity for F1000Research. (1)
Review activity for Journal of cardiovascular translational research. (2)
Review activity for Life. (1)
Review activity for Marine drugs. (1)
Review activity for Molecular biology reports. (1)
Review activity for Molecular therapy. (4)
Review activity for Non-coding RNA. (1)
Review activity for Signal transduction and targeted therapy. (1)
How many people are using ORCID?